NSE · MANIPALHOS.NS
Manipal Health Enterprises Limited
₹651.75+₹12.95 (+2.03%)
Manipal Health Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 20.17% below the high.
Loading market information…
NSE · FORTIS.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:14 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Fortis Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 28.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fortis Healthcare Limited’s forward annual dividend is ₹1.00 per share, paid annual. The forward yield is 0.13% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Fortis Healthcare Limited’s next earnings report is currently expected on Nov 14, 2026, with estimated earnings per share of ₹4.24. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fortis Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare Limited operates as an integrated provider of healthcare services. The company extends its offerings, which encompass secondary, tertiary, and quaternary medical care, across India, the United Arab Emirates, Sri Lanka, and other international markets. Its diverse healthcare infrastructure includes a network of hospitals, diagnostic facilities, and specialized day-care centers. Fortis delivers expertise across a broad spectrum of medical disciplines, including cardiology, cosmetic and dental sciences, dermatology, endocrinology, emergency medicine, ENT, fetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatment, internal medicine, mental and behavioral health, nephrology, neurosurgery, neurointervention, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy, plastic surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplant medicine, urology, and numerous other supporting specialties. By March 31, 2022, the company managed 26 hospitals, housing approximately 4,300 operational beds, in addition to around 426 diagnostic centers and laboratories, complemented by 2,550 collection centers.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:15 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 | May 20, 2025 | ₹2.39-11.48% vs estimate | ₹20.01B-0.86% vs estimate |
|---|
| Q3 2025 | Feb 7, 2025 | ₹3.00+33.93% vs estimate | ₹19.28B+2.05% vs estimate |
|---|
| Q2 2025 | Nov 8, 2024 | ₹3.02+12.27% vs estimate | ₹20.02B+1.41% vs estimate |
|---|
KEEP COMPARING
₹651.75+₹12.95 (+2.03%)
Manipal Health Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 20.17% below the high.
₹854.50+₹3.35 (+0.39%)
Max Healthcare Institute Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.17% below the high.
₹679.15-₹0.05 (-0.01%)
Aster DM Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 23.75% below the high.
₹1,725.20+₹10.70 (+0.62%)
Narayana Hrudayalaya Limited’s quoted price sits in the lower half of its reported 52-week range, 17.51% below the high.
₹1,302.50+₹2.80 (+0.22%)
Global Health Limited’s quoted price sits in the upper half of its reported 52-week range, 15.71% below the high.
₹700.95-₹1.55 (-0.22%)
Krishna Institute of Medical Sciences Limited’s quoted price sits in the lower half of its reported 52-week range, 18.27% below the high.
₹927.70+₹4.40 (+0.48%)
Yatharth Hospital & Trauma Care Services Limited’s quoted price sits in the upper half of its reported 52-week range, 21.55% below the high.
₹5,791.00-₹105.00 (-1.78%)
Kovai Medical Center and Hospital Limited’s quoted price sits in the upper half of its reported 52-week range, 10.13% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
